Shenzhen
300942.SZShenzhen Bioeasy Biotechnology Co., Ltd. Price (300942.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
401,973,412
(0.2778)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Shenzhen Bioeasy Biotechnology Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
87,046,831.00
+0% |
137,887,788.00
+58% |
204,933,431.00
+49% |
239,178,001.00
+17% |
258,455,671.00
+8% |
597,539,623.00
+131% |
686,897,476.00
+15% |
254,106,487.00
-63% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 22,094,624.00 | 33,796,917.00 | 64,790,335.00 | 65,859,668.00 | 63,668,193.00 | 169,510,206.00 | 298,761,963.00 | 127,232,415.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
64,952,207.00
+0% |
104,090,871.00
+60% |
140,143,096.00
+35% |
173,318,333.00
+24% |
194,787,478.00
+12% |
428,029,417.00
+120% |
388,135,513.00
-9% |
126,874,072.00
-67% |
|||||||||||
| Gross Profit Ratio | (0.75%) | (0.75%) | (0.68%) | (0.72%) | (0.75%) | (0.72%) | (0.57%) | (0.50%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 16,904,675.00 | 23,955,680.00 | 24,420,850.00 | 33,685,207.00 | 40,462,593.00 | 72,432,063.00 | 111,417,764.00 | 53,402,700.00 | |||||||||||
| General and Administrative | 14,557,801.00 | -17,837,477.33 | -24,930,971.29 | -31,636,681.16 | 19,719,266.00 | 19,200,060.00 | 30,154,168.00 | 23,764,354.00 | |||||||||||
| Selling, General & Admin... | 30,422,508.00 | 5,525,160.00 | 1,377,535.00 | 2,730,879.00 | 51,955,054.00 | 67,280,317.00 | 89,058,773.00 | 52,717,282.00 | |||||||||||
| Selling & Marketing Exp... | 15,864,706.00 | 23,362,637.00 | 26,308,507.00 | 34,367,560.00 | 32,235,787.00 | 48,080,256.00 | 58,904,605.00 | 28,952,928.00 | |||||||||||
| Depreciation and Amortiz... | 3,487,300.00 | 6,952,800.00 | 6,870,600.00 | 7,259,461.00 | 7,001,044.00 | 27,979,155.00 | 35,198,995.00 | 33,479,275.00 | |||||||||||
| Other Expenses | 10,526,661.00 | -941,240.09 | -2,203,474.89 | -2,126,542.63 | -1,161,678.07 | -237,545.38 | -3,221,239.33 | 196,314,681.00 | |||||||||||
| Total Operating Expenses | 48,212,035.00 | 58,399,589.00 | 56,185,809.00 | 75,411,934.00 | 102,244,711.00 | 160,081,435.00 | 250,431,291.00 | 302,175,259.00 | |||||||||||
| Cost and Exponses | 70,306,659.00 | 92,196,506.00 | 120,976,145.00 | 141,271,603.00 | 165,912,904.00 | 329,591,641.00 | 549,193,254.00 | 428,832,942.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
16,479,738.00
+0% |
44,458,567.00
+170% |
84,799,643.00
+91% |
105,237,914.00
+24% |
75,104,959.00
-29% |
268,277,090.00
+257% |
98,107,417.00
-63% |
-115,179,304.00
-217% |
|||||||||||
| Operating Income Ratio | (0.19%) | (0.32%) | (0.41%) | (0.44%) | (0.29%) | (0.45%) | (0.14%) | (-0.45%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 184,697.00 | 938,178.00 | 842,650.00 | 2,525,499.00 | 384,704.00 | 2,140,680.00 | 3,564,414.00 | 7,556,944.00 | |||||||||||
| Interest Expenses | 77,879.00 | 9,985.00 | 76,856.00 | 56,886.00 | 369,733.00 | 2,379,020.00 | 4,083,484.00 | 10,797,001.00 | |||||||||||
| Total Other Income/Exp... | 10,526,662.00 | -343,780.00 | -120,381.00 | 28,036,322.00 | -1,161,678.00 | -237,545.00 | -3,221,239.00 | -7,748,002.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 20,227,472.00 | 51,077,577.00 | 91,626,758.00 | 113,436,656.00 | 79,828,846.00 | 300,867,508.00 | 129,330,240.00 | -133,690,240.92 | |||||||||||
| EBITDA ratio | (0.24%) | (0.36%) | (0.43%) | (0.45%) | (0.37%) | (0.49%) | (0.26%) | (-0.53%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 27,006,400.00 | 44,114,787.00 | 84,679,262.00 | 106,037,735.00 | 73,943,281.00 | 268,039,545.00 | 94,886,178.00 | -122,927,306.00 | |||||||||||
| Income Before Tax Ratio | (0.31%) | (0.32%) | (0.41%) | (0.44%) | (0.29%) | (0.45%) | (0.14%) | (-0.48%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 3,586,124.00 | 4,849,338.00 | 10,766,485.00 | 13,749,435.00 | 8,493,880.00 | 31,569,540.00 | 12,222,382.00 | 7,185,311.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 23,438,995.00
+0% |
39,292,616.00
+68% |
73,936,739.00
+88% |
92,308,448.00
+25% |
65,445,058.00
-29% |
236,507,393.00
+261% |
82,965,490.00
-65% |
-184,907,769.00
-323% |
|||||||||||
| Net Income Ratio | (0.27%) | (0.28%) | (0.36%) | (0.39%) | (0.25%) | (0.40%) | (0.12%) | (-0.73%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 2.34 | 0.54 | 0.75 | 0.23 | 0.16 | 0.59 | 0.21 | -0.46 | |||||||||||
| Diluted EPS | 2.34 | 0.54 | 0.75 | 0.23 | 0.16 | 0.59 | 0.21 | -0.46 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 10,016,665.00 | 72,764,104.00 | 98,582,319.00 | 400,860,000.00 | 400,860,000.00 | 400,860,000.00 | 400,860,000.00 | 401,973,412.00 | |||||||||||
| Diluted Share Outstanding | 10,016,665.00 | 72,764,104.00 | 98,582,319.00 | 400,860,000.00 | 400,860,000.00 | 400,860,000.00 | 400,860,000.00 | 401,973,412.00 | |||||||||||